Delivery Order SPE2DB20D1100-SPE2DB25FC2E5
Award Date
5/8/25
Potential Completion Date
5/9/25
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $5,098.65 firm fixed price delivery order provides for the supply of the pharmaceutical products Amlodipine, Valsartan, and Hydrochlorothiazide in 30-count bottles. The award is associated with a $999,999,999.00 indefinite delivery contract (IDC) held by...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,437.87, is for the delivery of Amlodipine-Valsartan 10-320 mg tablets. This is a firm fixed-price delivery order contract with a completion date of February 13, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite...
This federal contract was awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,040.73 firm-fixed-price delivery order is for the supply of valsartan-hydrochlorothiazide 80-12.5 mg tablets, a common medication used to treat high blood pressure. The contract has a June 2024 completion date and is not designated as a set-aside. Amerisourcebergen is a major pharmaceutical distribution...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,431.78 and covers the delivery of Amlodipine-Valsartan 5-160 mg tablets. The contract is not set aside and allows for the supply of both brand-name and generic medications to support federal medical procurement needs, particularly for military and veteran...
This federal contract award is for the delivery of 4,565,964,777 units of the pharmaceutical product Amlodipine-Valsartan 10-160 mg, with a ceiling value of $1,270.76. The award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 27, 2024. This is a delivery order contract with a firm fixed price, and the ultimate completion date is September 30, 2024. The contract does not have a set-aside designation. As a large...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $4,616.44 and is for the delivery of Amlodipine-Valsartan 5-160 mg medication. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 5, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,797.74 contract is for the delivery of the pharmaceutical product Amlodipine Besylate, Valsartan, and Hydrochlorothiazide in 30-count packages. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) with DLA,...
This federal contract award, valued at $2,051.37, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Valsartan-HCTZ 320-25 mg tablets in 90-count packages, with an ultimate completion date of April 17, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Amlodipine-Valsartan-Hydrochlorothiazide (AMLOD-VALSA-HCTZ) 10-320-25 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $1,758.42, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on April 5, 2023. The award is a Delivery Order (DO) under an Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
This federal contract award for $11,637.96 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Valsartan-HCTZ 160-25 mg tablets. The order was issued as a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total ceiling value of up to $999,999,999 through December 2025. The contract does not utilize a set-aside designation and is for a firm fixed-price...